Barriers to the Access of Bevacizumab in Patients with Solid Tumors and the Potential Impact of Biosimilars: A Physician Survey.
about
Barriers to the Access of Bevacizumab in Patients with Solid Tumors and the Potential Impact of Biosimilars: A Physician Survey.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 28 January 2017
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Barriers to the Access of Beva ...... osimilars: A Physician Survey.
@en
Barriers to the Access of Beva ...... osimilars: A Physician Survey.
@nl
type
label
Barriers to the Access of Beva ...... osimilars: A Physician Survey.
@en
Barriers to the Access of Beva ...... osimilars: A Physician Survey.
@nl
prefLabel
Barriers to the Access of Beva ...... osimilars: A Physician Survey.
@en
Barriers to the Access of Beva ...... osimilars: A Physician Survey.
@nl
P2093
P2860
P356
P1433
P1476
Barriers to the Access of Beva ...... osimilars: A Physician Survey.
@en
P2093
Bradley J Monk
Ira Jacobs
Philip E Lammers
Thomas Cartwright
P2860
P356
10.3390/PH10010019
P577
2017-01-28T00:00:00Z